Raymond James & Associates’s Inovalon Holdings, Inc. Class A Common Stock INOV Stock Holding History

Raymond James & Associates’s Portfolio INOV Stock Details INOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,831	Closed	-$235K	–	4369
2021 Q3	$235K	Sell	5,831 -10,925	-65%	-$413K	﹤0.01%	3580
2021 Q2	$571K	Buy	16,756 +9,220	+122%	+$285K	﹤0.01%	2992
2021 Q1	$217K	Buy	+7,536	New	+$194K	﹤0.01%	3560
2020 Q4	–	Sell	-13,286	Closed	-$351K	–	3929
2020 Q3	$351K	Buy	+13,286	New	+$311K	﹤0.01%	2855
2020 Q2	–	Sell	-13,478	Closed	-$225K	–	3699
2020 Q1	$225K	Buy	+13,478	New	+$256K	﹤0.01%	2958

Raymond James & Associates's INOV Position: Q4 2021 in Review

Raymond James & Associates sold out of Inovalon Holdings, Inc. Class A Common Stock (INOV) in Q4 2021, closing a stake of 5,831 shares — an estimated $235K sold.

Raymond James & Associates first reported a position in INOV in Q1 2020 and held it in 5 quarters. The position peaked at $571K in Q2 2021. 0 funds tracked by Wall St. Rank hold INOV as of Q4 2021.

Raymond James & Associates reported no remaining Inovalon Holdings, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
Raymond James & Associates sold 5,831 Inovalon Holdings, Inc. Class A Common Stock shares in Q4 2021, an estimated $235K.
Raymond James & Associates first reported a position in Inovalon Holdings, Inc. Class A Common Stock in Q1 2020 and held it in 5 quarters.
Raymond James & Associates's Inovalon Holdings, Inc. Class A Common Stock position peaked at $571K in Q2 2021.
0 funds tracked by Wall St. Rank held Inovalon Holdings, Inc. Class A Common Stock as of Q4 2021.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.